Neurodegeneration with brain iron accumulation: genes and variants
Explore variant evidence for Neurodegeneration with brain iron accumulation across 2 analyzed proteins (WDR45, ATP13A2). Linked ClinVar records include 16 pathogenic or likely pathogenic variants, 74 variants of uncertain significance and 19 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Neurodegeneration with brain iron accumulation
WDR45: WD repeat domain phosphoinositide-interacting protein 4
It participates in early autophagosome formation and cellular recycling pathways, with neurons particularly vulnerable to its dysfunction. De novo or mosaic loss-of-function variants cause beta-propeller protein-associated neurodegeneration, with childhood developmental delay followed by progressive dystonia, parkinsonism, and brain iron accumulation.
15 ClinVar pathogenic / likely pathogenic and 93 uncertain variants in WDR45 have source records linked to Neurodegeneration with brain iron accumulation. Association strength is not clinical gene validity.
ATP13A2: Polyamine-transporting ATPase 13A2
It supports lysosomal and endolysosomal homeostasis and transports polyamines and other cationic substrates across intracellular membranes. Biallelic pathogenic variants cause Kufor-Rakeb syndrome and related early-onset parkinsonian-neurodegenerative phenotypes.
1 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ATP13A2 have source records linked to Neurodegeneration with brain iron accumulation. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Neurodegeneration with brain iron accumulation
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| WDR45 M1K | 1 | WD 1 | Pathogenic / likely pathogenic (★★) |
| WDR45 M1T | 1 | WD 1 | Pathogenic / likely pathogenic (★★) |
| WDR45 M1V | 1 | WD 1 | Pathogenic / likely pathogenic (★★) |
| ATP13A2 G504R | 504 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| WDR45 N61K | 61 | WD 2 | Pathogenic / likely pathogenic (★★) |
| WDR45 G167E | 167 | WD 4 | Pathogenic / likely pathogenic (★★) |
| WDR45 R232H | 232 | WD 6 | Pathogenic / likely pathogenic (★★) |
| WDR45 L57P | 57 | WD 2 | Pathogenic / likely pathogenic (★) |
| WDR45 L62P | 62 | WD 2 | Pathogenic / likely pathogenic (★) |
| WDR45 G67D | 67 | WD 2 | Pathogenic / likely pathogenic (★) |
| WDR45 L159P | 159 | WD 4 | Pathogenic / likely pathogenic (★) |
| WDR45 I188S | 188 | WD 5 | Pathogenic / likely pathogenic (★) |
| WDR45 G204D | 204 | WD 5 | Pathogenic / likely pathogenic (★) |
| WDR45 G214V | 214 | WD 5 | Pathogenic / likely pathogenic (★) |
| WDR45 R233L | 233 | WD 6 | Pathogenic / likely pathogenic (★) |
| WDR45 C310R | 310 | WD 7 | Pathogenic / likely pathogenic (★) |
Uncertain variants prioritized for review in Neurodegeneration with brain iron accumulation
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| WDR45 R233Q | 233 | WD 6 | Conflicting reports (★) | +7: 2 other pathogenic changes within 3 positions; R233L at the same position is pathogenic; seen in 9.1e-07 of gnomAD DNA copies; REVEL 0.778 |
| WDR45 R232C | 232 | WD 6 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; R232H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
Which prediction tools work for Neurodegeneration with brain iron accumulation
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 94 out of 100
- MutPred: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 92 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 90 out of 100
- MetaSVM: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 89 out of 100
- MetaLR: 88 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Diseases related to Neurodegeneration with brain iron accumulation
- Hereditary spastic paraplegia, also linked to ATP13A2
- Parkinson disease, also linked to ATP13A2
- Optic atrophy, also linked to WDR45
- Developmental disorder, also linked to WDR45
- Kufor-Rakeb syndrome, also linked to ATP13A2
Frequently asked questions
Which genes have records linked to Neurodegeneration with brain iron accumulation?
This view contains 2 analyzed proteins: WDR45, ATP13A2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 16 pathogenic or likely pathogenic variants, 74 variants of uncertain significance and 19 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 2 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 163 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center